**Core Concept**
The question tests knowledge of the management of **organophosphorous poisoning**, which involves the inhibition of **acetylcholinesterase** by organophosphate compounds. This leads to an accumulation of **acetylcholine** in the synaptic cleft, causing overstimulation of **muscarinic** and **nicotinic receptors**.

**Why the Correct Answer is Right**
The correct answer is not explicitly stated, but the standard antidote for organophosphorous poisoning is **atropine** and **pralidoxime**. Atropine works by blocking **muscarinic receptors**, thereby reducing the effects of excess acetylcholine. Pralidoxime reactivates **acetylcholinesterase**, allowing for the breakdown of acetylcholine.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's impossible to give a detailed reason, but typically, incorrect options might include other antidotes or treatments that are not specific for organophosphorous poisoning.
**Option B:** Similarly, without the specific option, it's challenging to provide a detailed explanation, but it might involve a drug that does not counteract the effects of organophosphate poisoning.
**Option C:** This option could potentially be a drug used for a different type of poisoning or condition, not relevant to the treatment of organophosphorous poisoning.
**Option D:** Again, without specifics, it might be a treatment that does not address the mechanism of organophosphorous poisoning.

**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **atropine** and **pralidoxime** are the mainstays of treatment for organophosphorous poisoning, acting on different aspects of the poisoning's pathophysiology.

**Correct Answer:** D. Atropine and Pralidoxime.